170
Participants
Start Date
September 27, 2012
Primary Completion Date
September 12, 2017
Study Completion Date
October 25, 2018
Nivolumab
Ipilimumab
Memorial Sloan-Kettering Cancer Center, New York
Sidney kimmel comprehensive cancer center at johns hopkins, Lutherville
University Of Virginia, Charlottesville
Local Institution - 0008, Pamplona
Vanderbilt-Ingram Cancer Ctr, Nashville
The University Of Texas MD Anderson Cancer Center, Houston
Ucla, Los Angeles
Providence Portland Medical Center, Portland
University of Washington - Seattle Cancer Care Alliance, Seattle
University Of Chicago, Chicago
Beth Israel Deaconess Medical Center (BIDMC), Boston
Dana Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
Local Institution - 0016, Amsterdam
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY